GlassScriptPhysician profile
Varun Reddy Danda
NPI 1922758523
$9,009.41
in general payments reported to CMS, 2019-2025
9 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $165 · 2023: $6,077 · 2024: $2,546 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,638 · Travel and Lodging: $1,592 · Food and Beverage: $1,564 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,638.38 |
| Travel and Lodging | $1,592.02 |
| Food and Beverage | $1,564.37 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,990.70 | 2022-2024 | Kyphon Express II Kyphopak Tray |
| Inari Medical, INC. | $2,123.98 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surmodics, INC. | $292.25 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Stryker Corporation | $185.33 | 2025 | Venacore Thrombectomy Catheter, Artix Mt, Clottriever Bold Catheter |
| Terumo Medical Corporation | $162.08 | 2024 | Tr Band, Angio-Seal |
| Penumbra, INC. | $156.90 | 2024 | Indigo System |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Bard Peripheral Vascular, INC. | $36.04 | 2025 | Porter |
| Lemaitre Vascular, INC. | $12.13 | 2023 | Restoreflow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Danda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.